362 Uric acid-lowering drugs can be broadly classified into three major groups: drugs that reduce uric acid synthesis (xanthine oxidase inhibitors), drugs that promote uric acid excretion (reabsorption inhibitors), and drugs that regulate uric acid metabolic hydrolysis (uricase inhibitors)
NASH has a close connection to other factors, such as high uric acid levels
432,433 One major consequence of CSC heterogeneity is the differential therapy response, where distinct CSC subpopulations display differential sensitivities to chemotherapy, radiotherapy, and targeted therapies
Managing Systemic Primary Carnitine Deficiency (SPCD) is a lifelong commitment to providing your body with the carnitine it cannot retain on its own [1]
A community of microorganisms including bacteria, located mainly in your intestines, that play an enormous role in our overall health
These are two of the most potent chemotherapeutic drugs, but also two of the most damaging to the kidney owing to the oxidative damage and severe inflammation they produce (Launay-Vacher 2008